• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Common Cold Partnering 2009-2014 Product Image

Common Cold Partnering 2009-2014

  • Published: March 2014
  • Region: Global
  • 100 pages
  • CurrentPartnering

FEATURED COMPANIES

  • Abbott
  • Baxter International
  • Dainippon Sumitomo
  • Grifols
  • Mitsubishi Tanabe
  • Servier
  • MORE

The Common Cold Partnering 2009-2014 provides understanding and access to the common cold partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of common cold partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors common cold technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 30 links to online copies of actual common cold deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract READ MORE >

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in common cold partnering

2.1. Introduction
2.2. Common cold partnering over the years
2.3. Bigpharma common cold dealmaking activity
2.4. Common cold partnering by deal type
2.5. Common cold partnering industry sector
2.6. Common cold partnering by stage of development
2.7. Common cold partnering by technology type
2.8. Disclosed financial deal terms for common cold partnering
2.8.1 Common cold headline values
2.8.2 Common cold upfront payments
2.8.3 Common cold milestone payments
2.8.4 Common cold royalty rates
Chapter 3 – Leading common cold deals

3.1. Introduction
3.2. Top common cold deals by value
3.3. Top common cold deals involving bigpharma
Chapter 4 – Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines
Chapter 5 – Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking
Appendices

Appendix 1 – Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports
Table of figures

Figure 1: Common cold partnering since 2009
Figure 2: Bigpharma – top 50 – common cold deals 2009 to 2011
Figure 3: Bigpharma common cold deal frequency – 2009 to 2011
Figure 4: Common cold partnering by deal type since 2009
Figure 5: Common cold partnering by industry sector since 2009
Figure 6: Common cold partnering by stage of development since 2009
Figure 7: Common cold partnering by technology type since 2009
Figure 8: Common cold deals with a headline value
Figure 9: Common cold deals with upfront payment values
Figure 10: Common cold deals with milestone payments
Figure 11: Common cold deals with royalty rates, %
Figure 12: Top common cold deals by value since 2009
Figure 13: Top common cold deals signed by bigpharma value since 2009
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions

Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Pain Partnering 2009-2014 - Product Thumbnail Image Pain Partnering 2009-2014

    Pain Partnering 2009-2014

    • Language: English
    • Published: March 2014
    • Region: Global
    FROM
  • Infectives Partnering Terms and Agreements - Product Thumbnail Image Infectives Partnering Terms and Agreements

    Infectives Partnering Terms and Agreements

    • Language: English
    • Published: March 2014
    • Region: Global
    FROM
  • Viral Partnering Terms and Agreements - Product Thumbnail Image Viral Partnering Terms and Agreements

    Viral Partnering Terms and Agreements

    • Language: English
    • Published: March 2014
    • Region: Global
    FROM
  • Accident & Emergency Partnering 2009-2014 - Product Thumbnail Image Accident & Emergency Partnering 2009-2014

    Accident & Emergency Partnering 2009-2014

    • Language: English
    • Published: March 2014
    • Region: Global
    FROM
  • Partnering Deals and Alliances with Big Pharma 7th Edition - Product Thumbnail Image Partnering Deals and Alliances with Big Pharma 7th Edition

    Partnering Deals and Alliances with Big Pharma 7th Edition

    • Language: English
    • 877 Pages
    • Published: July 2013
    • Region: Global
    FROM
  • Cardiovascular Partnering Terms and Agreements - Product Thumbnail Image Cardiovascular Partnering Terms and Agreements

    Cardiovascular Partnering Terms and Agreements

    • Language: English
    • 493 Pages
    • Published: March 2014
    • Region: Global
    FROM
  • Diabetes Partnering 2009-2014 - Product Thumbnail Image Diabetes Partnering 2009-2014

    Diabetes Partnering 2009-2014

    • Language: English
    • 300 Pages
    • Published: March 2014
    • Region: Global
    FROM
  • AIDS Partnering 2009-2014 - Product Thumbnail Image AIDS Partnering 2009-2014

    AIDS Partnering 2009-2014

    • Language: English
    • 1159 Pages
    • Published: March 2014
    • Region: Global
    FROM
  • Trends in Therapeutic Partnering - Product Thumbnail Image Trends in Therapeutic Partnering

    Trends in Therapeutic Partnering

    • Language: English
    • 3790 Pages
    • Published: August 2013
    • Region: Global
    FROM
  • Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    • Language: English
    • 1677 Pages
    • Published: July 2014
    • Region: Global
    FROM

Our Clients

Our clients' logos